Tirzepatide is a novel dual GIP/GLP-1 receptor activator. This medication has shown remarkable results in clinical trials for the treatment of type 2 diabetes. By acting on both the GIP and GLP-1 receptors, tirzepatide effectively improves blood glucose control. The dual mechanism of action of tirzepatide offers multiple potential improvements ove